Augmentation of coronary flow reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker

被引：0
|
作者：
Kawata, T
Toyoda, T
Hasegawa, R
Teramoto, K
Sekine, T
Maekawa, S
Lee, K
Uchida, D
Himi, T
Kuwabara, Y
机构：
[1] Chiba Univ, Grad Sch Med, Chiba, Japan
[2] Kimitsu Chuo Hosp, Kisarazu, Japan
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2002
引用
收藏
页码：425 / 425
页数：1
相关论文
共 50 条
  • [31] Comparison of Effects of Low Dose of Spironolactone and a Thiazide Diuretic in Patients with Hypertension Treated with an Angiotensin-Converting Enzyme Inhibitor or an Angiotensin Type 1 Receptor Blocker
    Yutaka, Miyashita
    Mifune, Mizuo
    Kubota, Eiji
    Itoh, Hiroshi
    Saito, Ikuo
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 2009, 31 (08) : 648 - 656
  • [32] Renal damage in the SHR/N-cp type 2 diabetes model:: Comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker
    Gross, ML
    Ritz, E
    Schoof, A
    Helmke, B
    Parkman, A
    Tulp, O
    Münter, K
    Amann, K
    LABORATORY INVESTIGATION, 2003, 83 (09) : 1267 - 1277
  • [33] SARS-CoV-2 and the Angiotensin-Converting Enzyme 2 Receptor: Angiotensin-Converting Enzyme Inhibitor/Angiotensin 2 Receptor Blocker Utilization and a Shift Towards the Renin-Angiotensin-Aldosterone System Classical Pathway
    Felber, Randy
    New, William
    Riskin, Suzanne I.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [34] The effect of combining angiotensin receptor blocker and angiotensin converting enzyme inhibitor on albuminuria in Type 2 diabetic patients with nephropathy
    Tan, F
    Liew, S
    Mukherjee, JJ
    Lee, KO
    Lim, P
    DIABETOLOGIA, 2004, 47 : A386 - A386
  • [35] Effect of angiotensin converting enzyme inhibitor and angiotensin II receptor blocker on the patients with sepsis
    Lee, Hyun Woo
    Suh, Jae Kyung
    Jang, Eunjin
    Lee, Sang-Min
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2021, 36 (02): : 371 - 381
  • [36] Comparison of angiotensin receptor antagonists with angiotensin-converting enzyme inhibitors fermentation of additional lateral diabetes mellitus type 2 nephropathy (Study DETAIL)
    Shestakova, M., V
    Shamaeva, E. N.
    DIABETES MELLITUS, 2005, 8 (01): : 6 - 8
  • [37] COMPARATIVE EFFECTIVENESS STUDY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS AND ANGIOTENSIN RECEPTOR BLOCKERS IN PATIENTS WITH TYPE 2 DIABETES
    Campbell, H. M.
    Khan, N.
    Raisch, D. W.
    Borrego, M.
    Sather, M.
    Murata, G. H.
    VALUE IN HEALTH, 2012, 15 (04) : A172 - A172
  • [38] Re: Is there a difference in the effect between the angiotensin-converting enzyme inhibitor and angiotensin-receptor blocker on the COVID-19?
    Liu, Xiao
    Long, Chuyan
    Xiong, Qinmei
    Chen, Chen
    Ma, Jianyong
    Su, Yuhao
    Hong, Kui
    CLINICAL CARDIOLOGY, 2021, 44 (01) : 7 - 8
  • [39] Angiotensin-(1-7) and apelin levels depending on 12-month treatment with angiotensin receptor blocker or angiotensin-converting enzyme inhibitor in patients with hypertension and type 2 diabetes
    Yushko, K.
    Koval, S.
    Snihurska, I.
    Starchenko, T.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 49 - 50
  • [40] Antihypertensive efficacy of the angiotensin receptor blocker azilsartan medoxomil compared with the angiotensin-converting enzyme inhibitor ramipril
    Boenner, G.
    Bakris, G. L.
    Sica, D.
    Weber, M. A.
    White, W. B.
    Perez, A.
    Cao, C.
    Handley, A.
    Kupfer, S.
    JOURNAL OF HUMAN HYPERTENSION, 2013, 27 (08) : 479 - 486
12345